[1] Thomas W, Downes K, Desborough MJR. Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management. Haemophilia. 2020;26(6):946-957. doi:10.1111/hae.14174
[2] Baker RI, Choi P, Curry N, et al. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024;22(7):2059-2070. doi:10.1016/j.jtha.2024.03.005
[3] Mehic D, Pabinger I, Gebhart J. Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out. Res Pract Thromb Haemost. 2023;7(8):102242. Published 2023 Oct 30. doi:10.1016/j.rpth.2023.102242.
[4] Ito Y, Tsuji S, Kasahara M, Tokoro S, Murakami T, Takayama H. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review. J Obstet Gynaecol Res. 2024;50(2):262-265. doi:10.1111/jog.15819.
[5] Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood. 2019;133(5):415-424. doi:10.1182/blood-2018-06-820738.
[6] Abdel-Samad N. Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency. Am J Case Rep. 2017;18:436-439. Published 2017 Apr 22. doi:10.12659/ajcr.901502.
[7] Xia W, Chen D, Li X, et al. Haplotypes analysis reveals the genetic basis of type I CD36 deficiency. Sci Rep. 2024;14(1):23977. Published 2024 Oct 14. doi:10.1038/s41598-024-74917-0.
[8] Yang YD, Dai WS, Zhang YL, Li DZ. Recurrent Fetal Hydrops with Severe Anemia and Thrombocytopenia Caused by Maternal CD36 Deficiency. Indian J Hematol Blood Transfus. 2026;42(3):1088-1090. doi:10.1007/s12288-025-02091-y.
[9] Setchell KD, Heubi JE, Shah S, et al. Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology. 2013;144(5):945-e15. doi:10.1053/j.gastro.2013.02.004.
[10] Caballero-Oteyza A, Crisponi L, Peng XP, et al. OTULIN-related conditions: Report of a new case and review of the literature using GenIA. Preprint. Res Sq. 2024;rs.3.rs-3950863. Published 2024 Mar 8. doi:10.21203/rs.3.rs-3950863/v2.
[11] Dou B, Jiang G, Peng W, Liu C. OTULIN deficiency: focus on innate immune system impairment. Front Immunol. 2024;15:1371564. Published 2024 May 7. doi:10.3389/fimmu.2024.1371564.
[12] Fijen LM, Riedl MA, Bordone L, et al. Inhibition of Prekallikrein for Hereditary Angioedema. N Engl J Med. 2022;386(11):1026-1033. doi:10.1056/NEJMoa2109329.
[13] Ji R, Xu Y, Zhi Y. Elevated level of circulating VEGF in Chinese patients with hereditary angioedema and its correlation with disease status. Orphanet J Rare Dis. 2025;20(1):251. Published 2025 May 26. doi:10.1186/s13023-025-03776-3.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications